B-Cell Immune Checkpoints Come of Age in Cardio-oncology
| Errataetall: |
CommentOn: Circ Res. 2024 Mar;134(5):550-568. - PMID 38323433 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:134 |
|---|---|
| Enthalten in: |
Circulation research - 134(2024), 5 vom: 05. März, Seite 569-571 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gutierrez, Alan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
80168379AG |
|---|
| Anmerkungen: |
Date Completed 04.03.2024 Date Revised 14.03.2024 published: Print-Electronic CommentOn: Circ Res. 2024 Mar;134(5):550-568. - PMID 38323433 Citation Status MEDLINE |
|---|
| doi: |
10.1161/CIRCRESAHA.124.324243 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369120981 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369120981 | ||
| 003 | DE-627 | ||
| 005 | 20240314235313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCRESAHA.124.324243 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1329.xml |
| 035 | |a (DE-627)NLM369120981 | ||
| 035 | |a (NLM)38422182 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gutierrez, Alan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a B-Cell Immune Checkpoints Come of Age in Cardio-oncology |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.03.2024 | ||
| 500 | |a Date Revised 14.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Circ Res. 2024 Mar;134(5):550-568. - PMID 38323433 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a B-cells | |
| 650 | 4 | |a Editorials | |
| 650 | 4 | |a cardio-oncology | |
| 650 | 4 | |a cardiotoxicity | |
| 650 | 4 | |a doxorubicin | |
| 650 | 4 | |a exercise | |
| 650 | 4 | |a immunity, innate | |
| 650 | 7 | |a Doxorubicin |2 NLM | |
| 650 | 7 | |a 80168379AG |2 NLM | |
| 700 | 1 | |a Moslehi, Javid J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Circulation research |d 1953 |g 134(2024), 5 vom: 05. März, Seite 569-571 |w (DE-627)NLM000001910 |x 1524-4571 |7 nnns |
| 773 | 1 | 8 | |g volume:134 |g year:2024 |g number:5 |g day:05 |g month:03 |g pages:569-571 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1161/CIRCRESAHA.124.324243 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 134 |j 2024 |e 5 |b 05 |c 03 |h 569-571 | ||